• KPMG provides annual actuarial report for asbestos-related disease liabilities
• Report effective as of March 31, 2026, based on claims data up to March 31, 2026
• Central estimate of liabilities for the Liable Entities is $1,351.1m
• Gross cashflow expenditure at $162.2m, 15% below expectations
• Net cashflow expenditure at $153.0m, 14% below expectations

KPMG has provided the Annual Actuarial Report for James Hardie Industries Plc, detailing the asbestos-related disease liabilities of the Liable Entities to be met by the AICF Trust, effective as of March 31, 2026. The report, prepared in accordance with the Amended Final Funding Agreement, is based on claims data and information provided by AICFL as of March 31, 2026. The report highlights a decrease in mesothelioma claims by 26% compared to the previous year, with 298 claims reported in 2025/26, which is 21% below expectations. The average claim awards for certain age cohorts were higher than expected, while others were lower. Gross cashflow expenditure was 15% below expectations at $162.2 million, and net cashflow expenditure was 14% below expectations at $153.0 million. The central estimate of liabilities for the Liable Entities is $1,351.1 million, which represents an increase of $30.8 million from the previous valuation due to changes in actuarial assumptions.

Central estimate of liabilities: $1,351.1 million as of March 31, 2026

The report indicates a decrease in claims and expenditure, with the central estimate of liabilities showing a slight increase due to changes in actuarial assumptions.